Mediclave Pharmaceuticals Private Limited
About Mediclave Pharmaceuticals Private Limited
Data last updated:
Mediclave Pharmaceuticals Private Limited was a private limited company based in Thane, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 09 July 2014.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2014PTC255944.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Ketan Jayant Desai and Satyen Pratap Shah.
Its last annual general meeting (AGM) was held on 21 August 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at Flat No. 11 Wing 22B Brindavan Vaibhav N.G Marg Brindaban, Thane, Maharashtra, India – 400601.
Company details
Contact details
Mediclave Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 11 Wing 22B Brindavan Vaibhav N.G Marg Brindaban, Thane, Maharashtra, India – 400601
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Mediclave Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Mediclave Pharmaceuticals Private Limited
FY 2019 filings availableFinancial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Mediclave Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mediclave Pharmaceuticals Private Limited
Mediclave Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ketan Jayant Desai | Director | 09 Jul 2014 | 12 Years 3 Months | As last reported |
| Satyen Pratap Shah | Director | 09 Jul 2014 | 12 Years 3 Months | As last reported |
Auditor
Mediclave Pharmaceuticals Private Limited is audited by S.C. BAPNA & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.C. BAPNA & ASSOCIATES | FY 2017 | 115649W |
Shareholding
The shareholding of Mediclave Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Mediclave Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mediclave Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mediclave Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Mediclave Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mediclave Pharmaceuticals Private Limited has 4 board changes on record since 2014: 2 appointments and 2 cessations. The latest: Ojasbhai Vasantbhai Khokhani ceased to be Director on 21 Nov 2019.
Frequently asked questions
Mediclave Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Mediclave Pharmaceuticals was a private limited company based in Thane, Maharashtra, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 09 July 2014 and is registered under CIN U24233MH2014PTC255944. The company has been struck off by the Registrar of Companies and is no longer operational.
Mediclave Pharmaceuticals had 2 directors:
- Ketan Jayant Desai - Director
- Satyen Pratap Shah - Director
The CIN (Corporate Identification Number) of Mediclave Pharmaceuticals is U24233MH2014PTC255944. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Mediclave Pharmaceuticals is at Flat No. 11 Wing 22B Brindavan Vaibhav N.G Marg Brindaban, Thane, Maharashtra, India – 400601.
Mediclave Pharmaceuticals was incorporated on 09 July 2014. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Mediclave Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 21 August 2019. Year-wise statements from 2015 are in the company report.
Mediclave Pharmaceuticals operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.
Ojasbhai Vasantbhai Khokhani ceased to be Director on 21 Nov 2019. Jigna Dhanraj Mehta ceased to be Additional Director on 27 Jun 2018. Ketan Jayant Desai was appointed as Director on 09 Jul 2014. Mediclave Pharmaceuticals has 4 board changes on record in total.
The compliance status of Mediclave Pharmaceuticals is compliant as of 29 September 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
